Correlation Between Day One and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Day One and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Day One and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Cullinan Oncology.
Diversification Opportunities for Day One and Cullinan Oncology
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Day and Cullinan is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Day One i.e., Day One and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Day One and Cullinan Oncology
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Cullinan Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.08 times less risky than Cullinan Oncology. The stock trades about -0.01 of its potential returns per unit of risk. The Cullinan Oncology LLC is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,161 in Cullinan Oncology LLC on August 24, 2024 and sell it today you would earn a total of 61.00 from holding Cullinan Oncology LLC or generate 5.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Day One Biopharmaceu |
| Cullinan Oncology LLC |
Day One and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Cullinan Oncology
The main advantage of trading using opposite Day One and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Day One vs. Lyra Therapeutics | Day One vs. Hookipa Pharma | Day One vs. Cingulate Warrants | Day One vs. SAB Biotherapeutics |
| Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Hookipa Pharma | Cullinan Oncology vs. Cingulate Warrants | Cullinan Oncology vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |